Since NRF2 can be activated by post-translational modification such as phosphorylation by various protein kinases (11), it is plausible that activation of NRF2 is mediated by oncogenic activation of upstream signaling pathway in cancer cells. This evidence concerns the gene WEE1 and cancer.